en

PRODUCT DETAIL

EVOTAZ 300 mg/150 mg filmom obalené tablety

Code 5715B
MA number EU/1/15/1025/002
Product Form: tbl flm 90(3x30)x300 mg/150 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR15 Atazanavir and cobicistat
Shelf life: 24
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 13.07.2015
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 17.05.2021
eu-flag.png sk-flag.png